David Schaffer
Founder bei Axent Biosciences, Inc.
Profil
David Schaffer is the founder of Valitor, Inc. (2010), Rewrite Therapeutics, Inc. (2016), 4D Molecular Therapeutics, Inc. (2013), and Axent Biosciences, Inc. (2019).
He held the title of Chief Scientific Advisor & Director at 4D Molecular Therapeutics, Inc. and Director & Chief Scientific Advisor at Axent Biosciences, Inc. Dr. Schaffer is also the founder of Ignite Immunotherapy, Inc. He currently holds the position of Director at California Institute For Quantitative Biosciences, Director at The Berkley Stem Cell Center, Professor at the University of California, Berkeley, and Scientific Advisor at Berkeley Frontier Fund.
Dr. Schaffer's former positions include Director at American Society of Gene Therapy, Director at Society for Biological Engineering, and Director at uniQure NV (2016-2020).
He was also an Associate Professor at the University of California from 1999 to 2007.
Dr. Schaffer received his undergraduate degree from Stanford University in 1993 and his doctorate from Massachusetts Institute of Technology in 1998.
Aktive Positionen von David Schaffer
| Unternehmen | Position | Beginn |
|---|---|---|
| University of California, Berkeley | Corporate Officer/Principal | 01.01.2007 |
| The Berkley Stem Cell Center | Director/Board Member | 01.01.2011 |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Consultant / Advisor | - |
Axent Biosciences, Inc.
 Axent Biosciences, Inc. BiotechnologyHealth Technology Axent Biosciences, Inc. engages as a biotechnology company. It develops stem cell therapies to address unmet medical needs in human diseases and disorders. The company is headquartered in Oakland, CA. | Founder | 01.12.2019 |
California Institute For Quantitative Biosciences
 California Institute For Quantitative Biosciences Investment ManagersFinance Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The private company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies. | Private Equity Investor | - |
Ehemalige bekannte Positionen von David Schaffer
| Unternehmen | Position | Ende |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Founder | 17.02.2022 |
| UNIQURE N.V. | Director/Board Member | 17.06.2020 |
| University of California | Corporate Officer/Principal | 01.01.2007 |
Rewrite Therapeutics, Inc.
 Rewrite Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Intellia Therapeutics, Inc., Rewrite Therapeutics, Inc. is a biotechnology company focused on novel DNA writing technologies. The private company is based in Emeryville, CA. The company was founded in 2016 by Shakked Halperin, David Schaffer. Shakked Halperin has been the CEO since 2016. Rewrite Therapeutics was acquired by Intellia Therapeutics, Inc. on February 04, 2022 for $200 million. | Founder | - |
| ░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Ausbildung von David Schaffer
| Stanford University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNIQURE N.V. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
| American Society of Gene Therapy | |
California Institute For Quantitative Biosciences
California Institute For Quantitative Biosciences Investment ManagersFinance Part of University of California, California Institute For Quantitative Biosciences is a biotech company that offers internships to UC students through its state-funded Qwest internship program. The private company is based in San Francisco, CA and was founded in 2000. The program places students with Bakar Labs tenant companies for work experience, and four of its first cohort have already received full-time job offers from their hosts. The company conducts proof-of-concept experiments in a mouse model of ALS and offers mentoring programs to early-stage companies. | Finance |
| Society for Biological Engineering | |
| The Berkley Stem Cell Center | |
Valitor, Inc.
 Valitor, Inc. BiotechnologyHealth Technology Valitor, Inc. develops a new generation of biotechnology drugs. It develops methods of modifying therapeutic proteins to achieve substantial control over pharmacokinetics, target specificity and bioactivity. The company was founded by Kevin E. Healy, Wesley M. Jackson and David Schaffer in 2010 and is headquartered in Berkeley, CA. | Health Technology |
Ignite Immunotherapy, Inc.
 Ignite Immunotherapy, Inc. BiotechnologyHealth Technology Part of Pfizer Inc., Ignite Immunotherapy, Inc. is a private company that designs and develops oncolytic virus vaccines. The company is based in New York, NY. The company was founded by David Schaffer, Douglas Hanahan, David H. Kirn, Theresa Janke, Melissa Kotterman. The CEO is Monika A. Vnuk. | Health Technology |
Axent Biosciences, Inc.
Axent Biosciences, Inc. BiotechnologyHealth Technology Axent Biosciences, Inc. engages as a biotechnology company. It develops stem cell therapies to address unmet medical needs in human diseases and disorders. The company is headquartered in Oakland, CA. | Health Technology |
Rewrite Therapeutics, Inc.
Rewrite Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Intellia Therapeutics, Inc., Rewrite Therapeutics, Inc. is a biotechnology company focused on novel DNA writing technologies. The private company is based in Emeryville, CA. The company was founded in 2016 by Shakked Halperin, David Schaffer. Shakked Halperin has been the CEO since 2016. Rewrite Therapeutics was acquired by Intellia Therapeutics, Inc. on February 04, 2022 for $200 million. | Commercial Services |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
